JP2005509634A5 - - Google Patents

Download PDF

Info

Publication number
JP2005509634A5
JP2005509634A5 JP2003537635A JP2003537635A JP2005509634A5 JP 2005509634 A5 JP2005509634 A5 JP 2005509634A5 JP 2003537635 A JP2003537635 A JP 2003537635A JP 2003537635 A JP2003537635 A JP 2003537635A JP 2005509634 A5 JP2005509634 A5 JP 2005509634A5
Authority
JP
Japan
Prior art keywords
formula
compound
amino
propanediol
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003537635A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005509634A (ja
Filing date
Publication date
Priority claimed from GBGB0125443.2A external-priority patent/GB0125443D0/en
Priority claimed from GB0127341A external-priority patent/GB0127341D0/en
Application filed filed Critical
Publication of JP2005509634A publication Critical patent/JP2005509634A/ja
Publication of JP2005509634A5 publication Critical patent/JP2005509634A5/ja
Pending legal-status Critical Current

Links

JP2003537635A 2001-10-23 2002-10-22 マクロライドを含む医薬組成物 Pending JP2005509634A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0125443.2A GB0125443D0 (en) 2001-10-23 2001-10-23 Organic Compounds
GB0127341A GB0127341D0 (en) 2001-11-14 2001-11-14 Organic compounds
PCT/EP2002/011799 WO2003035068A1 (en) 2001-10-23 2002-10-22 Macrolides containing pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JP2005509634A JP2005509634A (ja) 2005-04-14
JP2005509634A5 true JP2005509634A5 (https=) 2008-04-10

Family

ID=26246689

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003537635A Pending JP2005509634A (ja) 2001-10-23 2002-10-22 マクロライドを含む医薬組成物

Country Status (19)

Country Link
US (1) US7259170B2 (https=)
EP (1) EP1439838A1 (https=)
JP (1) JP2005509634A (https=)
KR (2) KR100978971B1 (https=)
CN (1) CN1307993C (https=)
AU (1) AU2002346859C1 (https=)
BR (1) BR0213463A (https=)
CA (1) CA2458690C (https=)
EC (1) ECSP045086A (https=)
GB (1) GB0125443D0 (https=)
HU (1) HUP0402108A3 (https=)
IL (1) IL160973A0 (https=)
MX (1) MXPA04003738A (https=)
NO (1) NO20042074L (https=)
NZ (1) NZ532412A (https=)
PL (1) PL368533A1 (https=)
RU (1) RU2321402C2 (https=)
WO (1) WO2003035068A1 (https=)
ZA (1) ZA200401711B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005512946A (ja) * 2001-05-09 2005-05-12 ノバルティス アクチエンゲゼルシャフト 選択的免疫調節法
BR0306811A (pt) 2002-01-11 2004-10-26 Sankyo Co Composto, éster farmacologicamente aceitável do mesmo, composição farmacêutica e métodos para prevenção ou tratamento de doenças autoimunes, da artrite reumatóide e da rejeição causada pelo transplante de vários órgãos em um mamìfero
GB0307867D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
JP2005272453A (ja) 2004-02-24 2005-10-06 Sankyo Co Ltd アミノアルコール化合物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68921934T2 (de) 1988-06-29 1995-10-19 Merck & Co Inc Immunsuppressives Agens.
DK0427680T3 (da) * 1989-11-09 1995-12-18 Sandoz Ltd Heteroatom-holdige cykliske forbindelser
US5352671A (en) * 1989-11-09 1994-10-04 Sandoz Ltd. Heteroatoms-containing tricyclic compounds
GB2252041A (en) * 1991-01-23 1992-07-29 Fujisawa Pharmaceutical Co Use of macrolide compounds in treatment of autoimmune myocarditis
CA2106483A1 (en) * 1991-03-19 1992-09-20 Vithal J. Rajadhyaksha Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
US5247076A (en) * 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
GB9203636D0 (en) * 1992-02-19 1992-04-08 Lucas Ind Plc Fuel pumping apparatus
US5604229A (en) * 1992-10-21 1997-02-18 Yoshitomi Pharmaceutical Industries, Ltd. 2-amino-1,3-propanediol compound and immunosuppressant
JPH08507789A (ja) 1993-03-17 1996-08-20 アボツト・ラボラトリーズ 大環状アミド及び尿素免疫調節剤
US5590460A (en) * 1994-07-19 1997-01-07 Tessera, Inc. Method of making multilayer circuit
DE69524962D1 (de) * 1994-08-22 2002-02-14 Welfide Corp Benzolderivate und deren medizinische verwendung
GB9521322D0 (en) 1995-10-17 1995-12-20 Sandoz Ltd Organic compounds
JPH11209277A (ja) 1998-01-19 1999-08-03 Yoshitomi Pharmaceut Ind Ltd 医薬組成物
GB9624038D0 (en) 1996-11-19 1997-01-08 Sandoz Ltd Organic compounds
ATE298740T1 (de) * 1997-04-04 2005-07-15 Mitsubishi Pharma Corp 2-aminopropan-1,3-diol-verbindungen, ihre medizinische anwendung und zwischenprodukte zu ihrer synthese
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
JP4627356B2 (ja) * 1999-06-30 2011-02-09 昭 松森 ウイルス性心筋炎の予防または治療薬剤
GB0003932D0 (en) 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
EP1355588B1 (en) 2000-12-22 2007-08-15 Avantec Vascular Corporation Device for delivery of therepeutic agents

Similar Documents

Publication Publication Date Title
ES2521672T3 (es) Formulaciones farmacéuticas para el tratamiento del cáncer
JP2005506352A5 (https=)
RU2007105568A (ru) Эффективный способ использования лекарственных средств и способ предотвращения выраженности побочных эффектов
JP2004531517A5 (https=)
JP2008514732A5 (https=)
JP2008521827A5 (https=)
RU99112577A (ru) Новое применение 1,3-пропандиольных производных
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
RU2008116578A (ru) Применение ингибиторов dpp-iv для лечения аутоиммунных заболеваний и отторжения трансплантата
US20080015261A1 (en) Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function
ES2356986T3 (es) Agentes antitumorales.
EP4520394A3 (en) New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
RU2004131214A (ru) Способы лечения когнитивных расстройств
JP2002539089A5 (https=)
RU2005133665A (ru) Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств
JP2005509634A5 (https=)
Galanello Iron chelation: new therapies
JPH1036365A5 (https=)
JP2007529545A (ja) ダウン症候群の治療法
RU2002102076A (ru) Фармацевтическая композиция, содержащая сибутрамин и орлистат
JP2002522462A5 (https=)
JP2003534318A5 (https=)
JP2003534317A5 (https=)
RU2009149637A (ru) Композиции, применимые для лечения гастроэзофагеальной рефлюксной болезни
CA2468811A1 (en) Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders